XML 15 R5.htm IDEA: XBRL DOCUMENT v3.19.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Earnings (Deficit)
Balance at Dec. 31, 2017 $ 591,548 $ 436 $ 628,983 $ (6,363) $ (31,508)
Balance (in shares) at Dec. 31, 2017   43,587,079      
Net income 6,185       6,185
Issuance of common stock for debt conversion 0 $ 0 0    
Issuance of common stock for debt conversion (in shares)   2      
Exercise of stock options and releases of restricted stock 1,490 $ 2 1,488    
Exercise of stock options and releases of restricted stock (in shares)   211,491      
Stock-based compensation expense 4,893   4,893    
Cumulative effect of accounting changes at Dec. 31, 2017 (677)       (677)
Translation adjustment at Dec. 31, 2017 (4,780)     (4,780)  
Balance at Jun. 30, 2018 598,659 $ 438 635,364 (11,143) (26,000)
Balance (in shares) at Jun. 30, 2018   43,798,572      
Balance at Mar. 31, 2018 597,183 $ 437 631,595 (6,112) (28,737)
Balance (in shares) at Mar. 31, 2018   43,692,303      
Net income 2,738       2,737
Issuance of common stock for debt conversion   $ 0 0    
Exercise of stock options and releases of restricted stock 1,145 $ 1 1,144    
Exercise of stock options and releases of restricted stock (in shares)   106,269      
Stock-based compensation expense 2,625   2,625    
Translation adjustment at Mar. 31, 2018 (5,031)     (5,031)  
Balance at Jun. 30, 2018 598,659 $ 438 635,364 (11,143) (26,000)
Balance (in shares) at Jun. 30, 2018   43,798,572      
Balance at Dec. 31, 2018 615,568 $ 439 642,590 (11,893) (15,568)
Balance (in shares) at Dec. 31, 2018   43,917,378      
Net income 16,148       16,148
Issuance of common stock for debt conversion 2 $ 0 2    
Issuance of common stock for debt conversion (in shares)   29      
Exercise of stock options and releases of restricted stock 566 $ 3 563    
Exercise of stock options and releases of restricted stock (in shares)   245,263      
Issuance of common stock pursuant to the acquisition of C Technologies, Inc. 53,938 $ 8 53,930    
Issuance of common stock pursuant to the acquisition of C Technologies, Inc., (in shares)   779,221      
Proceeds from issuance of common stock, net of issuance costs of $0.5 million 189,623 $ 31 189,592    
Proceeds from issuance of common stock, net of issuance costs of $0.5 million (in shares)   3,144,531      
Stock-based compensation expense 6,283   6,283    
Translation adjustment at Dec. 31, 2018 (3,160)     (3,160)  
Balance at Jun. 30, 2019 878,968 $ 481 892,960 (15,053) 580
Balance (in shares) at Jun. 30, 2019   48,086,422      
Balance at Mar. 31, 2019 625,025 $ 441 645,883 (13,784) (7,515)
Balance (in shares) at Mar. 31, 2019   44,073,998      
Net income 8,095       8,095
Issuance of common stock for debt conversion 2 $ 0 2    
Issuance of common stock for debt conversion (in shares)   29      
Exercise of stock options and releases of restricted stock 523 $ 1 522    
Exercise of stock options and releases of restricted stock (in shares)   88,643      
Issuance of common stock pursuant to the acquisition of C Technologies, Inc. 53,938 $ 8 53,930    
Issuance of common stock pursuant to the acquisition of C Technologies, Inc., (in shares)   779,221      
Proceeds from issuance of common stock, net of issuance costs of $0.5 million 189,623 $ 31 189,592    
Proceeds from issuance of common stock, net of issuance costs of $0.5 million (in shares)   3,144,531      
Stock-based compensation expense 3,031   3,031    
Translation adjustment at Mar. 31, 2019 (1,269)     (1,269)  
Balance at Jun. 30, 2019 $ 878,968 $ 481 $ 892,960 $ (15,053) $ 580
Balance (in shares) at Jun. 30, 2019   48,086,422